Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasma-derived C1-inhibitor concentrate: a case report
Hereditary angioedema (HAE) is a rare autosomal dominant disease caused by quantitative (type I) or functional (type II) deficiency in C1 esterase inhibitor (C1-INH). It may be caused by new mutations in up to 20% of patients. Prevalence of HAE is uncertain but is estimated to be approximately 1 cas...
Main Authors: | D. V. Demina, A. O. Makeeva, L. M. Kudelya, E. V. Novikova, V. A. Kozlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2021-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2062 |
Similar Items
-
Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
by: Yinshi Guo, et al.
Published: (2022-11-01) -
Using an extended treatment regimen of lanadelumab in the prophylaxis of hereditary angioedema: a single-centre experience
by: Mohamed Abuzakouk, PhD, et al.
Published: (2022-07-01) -
Hereditary angioedema: approaches to diagnosis and treatment, analysis of a clinical family case
by: O. V. Skorohodkina, et al.
Published: (2021-09-01) -
Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
by: Natalia Gabriel, et al.
Published: (2022-02-01) -
Short-term Prophylaxis for Delivery in Pregnant Women with Hereditary Angioedema with Normal C1-Inhibitor
by: Caroline Guth de Freitas Batista de Moraes, et al.
Published: (2021-01-01)